Risedronate sodium is used for: Treatment and prevention of osteoporosis in postmenopausal women. Osteoporosis in men and due to long-term corticosteroid use. Paget’s disease of bone. It strengthens bones by inhibiting osteoclast-mediated bone resorption. It is grouped under the following drug class(es): Bisphosphonates. Its therapeutic use is listed as anti-osteoporosis agents. The directory classifies it as a commercial API with a synthetic source/manufacturing origin. Other names for this substance include Actonel, Atelvia and Benet. Its PubChem CID is 4194514.
Risedronate sodium
| CAS No | 115436-72-1 |
|---|---|
| Molecular Formula | C7H10NNaO7P2 |
| Molecular Weight | 305.09 g/mol |
| Synonyms | sodium;hydroxy-(1-hydroxy-1-phosphono-2-pyridin-3-ylethyl)phosphinate |
Zoho Contact Form
"*" indicates required fields
Frequently Asked Questions
Risedronate sodium is used for: Treatment and prevention of osteoporosis in postmenopausal women. Osteoporosis in men and due to long-term corticosteroid use. Paget’s disease of bone.
The listed CAS number is 115436-72-1.
The listed molecular formula is C7H10NNaO7P2.
The listed molecular weight is 305.09 g/mol.
sodium;hydroxy-(1-hydroxy-1-phosphono-2-pyridin-3-ylethyl)phosphinate.
The source lists Actonel, Atelvia and Benet.